Trial Profile
Functional Impact of GLP-1 for Heart Failure Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
- Acronyms FIGHT
- 26 Dec 2022 Results of post-hoc analysis assessing the effect of liraglutide (vs. placebo) on the totality of events in patients with heart failure with reduced ejection fraction, published in the Diabetes, Obesity and Metabolism.
- 14 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 16 Oct 2013 New source identified and integrated (Mayo Clinic, 12-009924).